IGEM:Harvard/2006/DNA nanostructures/Notebook/2006-8-23: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
No edit summary
Line 30: Line 30:
== PEG fractionation (from [[IGEM:Harvard/2006/DNA_nanostructures/Notebook/2006-8-20|8-20]]) ==
== PEG fractionation (from [[IGEM:Harvard/2006/DNA_nanostructures/Notebook/2006-8-20|8-20]]) ==
Also including 8% and 10% PEG fractionation for c6.0.A, c6.0.B, and c6.0.C
Also including 8% and 10% PEG fractionation for c6.0.A, c6.0.B, and c6.0.C
==Streptavidin Depletion Assay==
===Plans===
*Possible Issues and Solutions
**Too much DNA; even if a reasonable amount (say 70% of the biotinylated sites) are binding strep, there wouldn't be a noticeable difference between the bead-treated boxes and non-bead-treated boxes.
***Lower amount of DNA used to half a reaction.
****But the bands aren't that bright as it is, despite the iris being completely open, manual exposure, and use of 5uL of EtBr - possibly due to DNA leeching out during the long (>2hour) electrophoresis?  Is that likely at all?  But at the same time, my gels have been coming out fainter and fainter as I run longer each time, and yesterday it wasn't even left in buffer for any amount of time at all. 
*****Run at higher voltage (100V), shorter time (1.5hr) - the difficulty in differentiating the folded from the scaffold might be due recently to the switchover to 0.5xTBE.  Take a risk with the higher voltage - check on the gel box every 20 minutes to make sure no boiling is occuring, and scrape off the electrode wire each time.
**Too little free streptavidin
***Overload with free streptavidin - add from the original stock tube, which is likely safer (in more accurate-for-streptavidin-efficacy) buffer than the dilutions that have been made.  This should push the equilibrium towards more complete binding of sites.
**Biotinylated stuff not binding.
***Check by running a control of biotinylated oligos (untreated, beaded, free streped, free then beaded) - there are large amounts of the original tube oligos, so run 40pmol of biotinylated sites (10uM biotinylated sites in the pre-working stock = 10pmoles/uL), or 5uL (to account for inefficient binding and pipetting error) in one lane and 40uL in another, just to make sure that the binding actually works.
****If oligos don't show up in the untreated lane, try SYBR gold staining - ssDNA will show up better at low concentrations that way.
**Suspicion that the magnetic beads may work better because there's no worry of accidentally loading part of the pellet and, thus, bead-bound material.
***Use magnetic beads, concentrated with the MagnaRack initially, and run high concentrations (ie. low total volumes).
===Folded:===
*4 rxns each of:
**c5.0.A lidless
**c5.0.Eb
**(4 rxns of c5.0.Fb remain from Katie's foldings on Monday)
*NB: Noticed that there were errors in the pre-working stock table.  See [[Table_of_c5.0_Working_Stocks|c5.0 Table of Working Stocks]].
**Had to mix:
***c5.0.Eb
***c5.0.Fb

Revision as of 18:19, 23 August 2006

Verify folding of design 5 and 6

Ran gel to verify folding from earlier this week. Also comparing new scaffold with old scaffold.

design 5 and 6 folding, old and new scaffold comparison
Lane Contents
1 ladder
2 p7308 old
3 p7308 new
4 c5.0.A (old scaffold)
5 c5.0.A (new scaffold)
6 c5.0.C
7 c5.0.D
8 c6.0.A
9 c6.0.B
10 c6.0.C

PEG fractionation (from 8-20)

Also including 8% and 10% PEG fractionation for c6.0.A, c6.0.B, and c6.0.C


Streptavidin Depletion Assay

Plans

  • Possible Issues and Solutions
    • Too much DNA; even if a reasonable amount (say 70% of the biotinylated sites) are binding strep, there wouldn't be a noticeable difference between the bead-treated boxes and non-bead-treated boxes.
      • Lower amount of DNA used to half a reaction.
        • But the bands aren't that bright as it is, despite the iris being completely open, manual exposure, and use of 5uL of EtBr - possibly due to DNA leeching out during the long (>2hour) electrophoresis? Is that likely at all? But at the same time, my gels have been coming out fainter and fainter as I run longer each time, and yesterday it wasn't even left in buffer for any amount of time at all.
          • Run at higher voltage (100V), shorter time (1.5hr) - the difficulty in differentiating the folded from the scaffold might be due recently to the switchover to 0.5xTBE. Take a risk with the higher voltage - check on the gel box every 20 minutes to make sure no boiling is occuring, and scrape off the electrode wire each time.
    • Too little free streptavidin
      • Overload with free streptavidin - add from the original stock tube, which is likely safer (in more accurate-for-streptavidin-efficacy) buffer than the dilutions that have been made. This should push the equilibrium towards more complete binding of sites.
    • Biotinylated stuff not binding.
      • Check by running a control of biotinylated oligos (untreated, beaded, free streped, free then beaded) - there are large amounts of the original tube oligos, so run 40pmol of biotinylated sites (10uM biotinylated sites in the pre-working stock = 10pmoles/uL), or 5uL (to account for inefficient binding and pipetting error) in one lane and 40uL in another, just to make sure that the binding actually works.
        • If oligos don't show up in the untreated lane, try SYBR gold staining - ssDNA will show up better at low concentrations that way.
    • Suspicion that the magnetic beads may work better because there's no worry of accidentally loading part of the pellet and, thus, bead-bound material.
      • Use magnetic beads, concentrated with the MagnaRack initially, and run high concentrations (ie. low total volumes).

Folded:

  • 4 rxns each of:
    • c5.0.A lidless
    • c5.0.Eb
    • (4 rxns of c5.0.Fb remain from Katie's foldings on Monday)
    • Had to mix:
      • c5.0.Eb
      • c5.0.Fb